StonvexLoading…
StonvexCore line items from BBWI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-02-01 | Annual 2024 2024-02-03 | Annual 2023 2023-01-28 |
|---|---|---|---|---|
Revenue | $7.29B | $7.31B | $7.43B | $7.56B |
Operating Income | $1.13B | $1.27B | $1.28B | $1.38B |
Net Income | $649.00M | $798.00M | $878.00M | $800.00M |
EPS (Diluted) | $3.11 | $3.61 | $3.84 | $3.43 |
Total Assets | $5.07B | $4.87B | $5.46B | $5.49B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $953.00M | $674.00M | $1.08B | $1.23B |
Free Cash Flow OCF − CapEx | $865.00M | $660.00M | $656.00M | $816.00M |
Shares Outstanding | 201.00M | 216.00M | 225.00M | 229.00M |